Search results
Deciphera (DCPH) Issues Strategic & Corporate Outlook for 2023
Zacks via Yahoo Finance· 1 year agoDeciphera (DCPH) provides a strategic outlook and planned corporate milestones for 2023. The company...
The Deciphera Pharmaceuticals Inc (DCPH) Company: A Short SWOT Analysis
GuruFocus.com via Yahoo Finance· 6 months agoDeciphera Pharmaceuticals Inc (NASDAQ:DCPH) has shown a significant increase in product revenues,...
Deciphera (DCPH) Q2 Earnings Beat, Qinlock Drives Revenues
Zacks via Yahoo Finance· 8 months agoDeciphera Pharmaceuticals, Inc. DCPH reported second-quarter 2023 loss of 57 cents per share,...
Can Deciphera Pharmaceuticals, Inc. (DCPH) Climb 79% to Reach the Level Wall Street Analysts Expect?
Zacks via Yahoo Finance· 2 years agoThe consensus price target hints at a 78.9% upside potential for Deciphera Pharmaceuticals, Inc....
Deciphera (DCPH) Q1 Earnings Match Estimates, Sales Miss
Zacks via Yahoo Finance· 12 months agoDeciphera Pharmaceuticals (DCPH) reports mixed first-quarter 2023 results as its earnings are in...
Is Deciphera Pharmaceuticals (DCPH) Stock Outpacing Its Medical Peers This Year?
Zacks via Yahoo Finance· 2 years agoInvestors interested in Medical stocks should always be looking to find the best-performing...
Deciphera Pharmaceuticals (DCPH): A Closer Look at Its Undervalued Status
GuruFocus.com via Yahoo Finance· 7 months agoDeciphera Pharmaceuticals Inc (NASDAQ:DCPH) recently reported a daily gain of 5.06%, despite a...
Deciphera Pharmaceuticals, Inc. (DCPH) Expected to Beat Earnings Estimates: Can the Stock Move...
Zacks via Yahoo Finance· 2 years agoDeciphera Pharmaceuticals, Inc. (DCPH) possesses the right combination of the two key ingredients...